Abstract
N-methyl-D-aspartate (NMDA) receptors play a key role in excitatory neurotransmission and are linked to a variety of acute and chronic neurodegenerative diseases including epilepsy, schizophrenia, Parkinson's disease and drug abuse. N-(2-chloro-5-methylthiophenyl)-N′-(3- rnethylthiophenyl)-N′-methylguanidine (CNS 5161) is a high affinity ligand (Ki = 1.87 ± 0.25 nM) for the NMDA PCP site, which potentially can be used for functional imaging of this receptor. Herein we report the synthesis of the corresponding positron emission tomography (PET) tracer [11C]CNS 5161 by means of [11C]methylation of the desmethyl guanidine precursor. [11C]CNS 5161 was synthesized with a decay corrected radiochemical yield of 10% within 45 min after end of bombardment (EOB). The final product was prepared in a sterile saline solution suitable for clinical studies with a radiochemical purity of >96% and a specific activity of 41 GBq/mmol at time of injection. Copyright if 2005 John Wiley & Sons, Ltd.
Original language | English |
---|---|
Pages (from-to) | 163-170 |
Number of pages | 8 |
Journal | Journal of Labelled Compounds and Radiopharmaceuticals |
Volume | 49 |
Issue number | 2 |
DOIs | |
Publication status | Published or Issued - Feb 2006 |
Externally published | Yes |
Keywords
- CNS 5161
- Glutamate
- NMDA
- PET
- Radiotracer
ASJC Scopus subject areas
- Analytical Chemistry
- Biochemistry
- Radiology Nuclear Medicine and imaging
- Drug Discovery
- Spectroscopy
- Organic Chemistry